These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15809822)

  • 1. Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G
    J Neurol; 2005 Oct; 252(10):1186-93. PubMed ID: 15809822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine as a possible treatment for anxiety due to vascular dementia: an open study.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G; Bava A
    Am J Alzheimers Dis Other Demen; 2004; 19(2):81-8. PubMed ID: 15106388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients.
    Moretti R; Torre P; Antonello RM; Cazzato G; Griggio S; Bava A
    Am J Alzheimers Dis Other Demen; 2003; 18(4):205-14. PubMed ID: 12955785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
    Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
    Chiabrando G; Bianchi S; Poluzzi E; Montanaro N; Scanavacca P
    Eur J Clin Pharmacol; 2010 Jul; 66(7):661-9. PubMed ID: 20464383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.
    Moretti R; Torre P; Antonello RM; Pizzolato G
    Expert Rev Neurother; 2006 May; 6(5):705-10. PubMed ID: 16734518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do atypical antipsychotics cause stroke?
    Herrmann N; Lanctôt KL
    CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.
    Schneider LS; Dagerman K; Insel PS
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):191-210. PubMed ID: 16505124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.
    Kryzhanovskaya LA; Jeste DV; Young CA; Polzer JP; Roddy TE; Jansen JF; Carlson JL; Cavazzoni PA
    J Clin Psychiatry; 2006 Jun; 67(6):933-45. PubMed ID: 16848653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
    Martin H; Slyk MP; Deymann S; Cornacchione MJ
    J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.
    Deberdt WG; Dysken MW; Rappaport SA; Feldman PD; Young CA; Hay DP; Lehman DL; Dossenbach M; Degenhardt EK; Breier A
    Am J Geriatr Psychiatry; 2005 Aug; 13(8):722-30. PubMed ID: 16085789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
    Deberdt WG; Siegal A; Ahl J; Meyers AL; Landbloom R
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):364-9. PubMed ID: 17708584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.
    Street JS; Clark WS; Kadam DL; Mitan SJ; Juliar BE; Feldman PD; Breier A
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S62-70. PubMed ID: 11748789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective observational study of outpatients with schizophrenia in Poland: preliminary 6 month efficacy and tolerability results].
    Meder J; Debowska G; Lis J; Araszkiewicz A; Sierosławska K; Kolesaric A; Treuer T
    Psychiatr Pol; 2004; 38(3):469-84. PubMed ID: 15199656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The switching of risperidone to olanzapine in elderly nursing-home patients with dementia: a retrospective study.
    Madhusoodanan S; Bogunovic O
    CNS Spectr; 2007 Jan; 12(1):46-50. PubMed ID: 17192763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S; Hazra A; Ghosh M
    Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.